Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection.

dc.contributor.authorLalueza, A
dc.contributor.authorAyuso, B
dc.contributor.authorArrieta, E
dc.contributor.authorTrujillo, H
dc.contributor.authorFolgueira, D
dc.contributor.authorCueto, C
dc.contributor.authorSerrano, A
dc.contributor.authorLaureiro, J
dc.contributor.authorArévalo-Cañas, C
dc.contributor.authorCastillo, C
dc.contributor.authorDíaz-Pedroche, C
dc.contributor.authorLumbreras, C
dc.contributor.authorINFLUDOC group
dc.date.accessioned2025-01-07T13:13:55Z
dc.date.available2025-01-07T13:13:55Z
dc.date.issued2020-02-28
dc.description.abstractThere is increasing evidence that ferritin is a key marker of macrophage activation, but its potential role in influenza infection remains unexplored. Our aim was to assess whether hyperferritinaemia (ferritin ≥500 ng/mL) could be a marker of poor prognosis in hospitalized patients with confirmed influenza A infection. We prospectively recruited all hospitalized adult patients who tested positive for the influenza A rRT-PCR assay performed on respiratory samples in two consecutive influenza periods (2016-17 and 2017-18). Poor outcome was defined as the presence of at least one of the following: respiratory failure, admission to the intensive care unit, or in-hospital mortality. Among 494 patients, 68 (14%) developed poor outcomes; 112 patients (23%) had hyperferritinaemia (39/68, 57% in the poor-outcome group versus 73/426, 17% in the remaining patients, p  Serum ferritin may discriminate a subgroup of patients with influenza infection who have a higher risk of developing a poor outcome.
dc.identifier.doi10.1016/j.cmi.2020.02.018
dc.identifier.essn1469-0691
dc.identifier.pmid32120038
dc.identifier.unpaywallURLhttp://www.clinicalmicrobiologyandinfection.com/article/S1198743X20301002/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25349
dc.issue.number11
dc.journal.titleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
dc.journal.titleabbreviationClin Microbiol Infect
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.page.number1557.e9-1557.e15
dc.pubmedtypeJournal Article
dc.pubmedtypeObservational Study
dc.rights.accessRightsopen access
dc.subjectFerritin
dc.subjectHyperferritinaemia
dc.subjectInfluenza
dc.subjectOutcome
dc.subjectRespiratory failure
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshCritical Care
dc.subject.meshFemale
dc.subject.meshFerritins
dc.subject.meshHospital Mortality
dc.subject.meshHospitalization
dc.subject.meshHumans
dc.subject.meshInfluenza A virus
dc.subject.meshInfluenza, Human
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPrognosis
dc.subject.meshProspective Studies
dc.subject.meshRespiratory Insufficiency
dc.subject.meshUp-Regulation
dc.titleElevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number26

Files